Khaznadar, F.;                     Petrovic, A.;                     Khaznadar, O.;                     Roguljic, H.;                     Bojanic, K.;                     Kuna Roguljic, L.;                     Siber, S.;                     Smolic, R.;                     Bilic-Curcic, I.;                     Wu, G.Y.;     
    et al.    Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy. J. Clin. Med. 2023, 12, 6561.
    https://doi.org/10.3390/jcm12206561
    AMA Style
    
                                Khaznadar F,                                 Petrovic A,                                 Khaznadar O,                                 Roguljic H,                                 Bojanic K,                                 Kuna Roguljic L,                                 Siber S,                                 Smolic R,                                 Bilic-Curcic I,                                 Wu GY,         
        et al.        Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy. Journal of Clinical Medicine. 2023; 12(20):6561.
        https://doi.org/10.3390/jcm12206561
    
    Chicago/Turabian Style
    
                                Khaznadar, Farah,                                 Ana Petrovic,                                 Omar Khaznadar,                                 Hrvoje Roguljic,                                 Kristina Bojanic,                                 Lucija Kuna Roguljic,                                 Stjepan Siber,                                 Robert Smolic,                                 Ines Bilic-Curcic,                                 George Y. Wu,         
         and et al.        2023. "Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy" Journal of Clinical Medicine 12, no. 20: 6561.
        https://doi.org/10.3390/jcm12206561
    
    APA Style
    
                                Khaznadar, F.,                                 Petrovic, A.,                                 Khaznadar, O.,                                 Roguljic, H.,                                 Bojanic, K.,                                 Kuna Roguljic, L.,                                 Siber, S.,                                 Smolic, R.,                                 Bilic-Curcic, I.,                                 Wu, G. Y.,                                 & Smolic, M.        
        
        (2023). Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy. Journal of Clinical Medicine, 12(20), 6561.
        https://doi.org/10.3390/jcm12206561